Dashboard
Manage Tickers

TVTX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
10 Health Care Stocks With Whale Alerts In...
09/29/2025 17:35:29

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and...

Core News & Articles
KDIGO 2025 Guidelines Endorse FILSPARI By ...
09/26/2025 07:24:20

FILSPARI (sparsentan) suggested for IgA Nephropathy patients who are at risk of progressive kidney function loss

the-analyst-verdict-travere-therapeutics-in-the-eyes-of-9-experts
The Analyst Verdict: Travere Therapeutics ...
09/19/2025 13:01:29

hc-wainwright--co-reiterates-buy-on-travere-therapeutics-maintains-47-price-target
HC Wainwright & Co. Reiterates Buy on Trav...
09/19/2025 12:19:12

HC Wainwright & Co. analyst Joseph Pantginis reiterates Travere Therapeutics (NASDAQ:TVTX) with a Buy and maintains $47 ...

stifel-maintains-hold-on-travere-therapeutics-raises-price-target-to-25
Stifel Maintains Hold on Travere Therapeut...
09/12/2025 14:29:00

Stifel analyst Alex Thompson maintains Travere Therapeutics (NASDAQ:TVTX) with a Hold and raises the price target from $20 t...

wells-fargo-maintains-overweight-on-travere-therapeutics-raises-price-target-to-35
Wells Fargo Maintains Overweight on Traver...
09/11/2025 12:38:37

Wells Fargo analyst Mohit Bansal maintains Travere Therapeutics (NASDAQ:TVTX) with a Overweight and raises the price target ...

travere-shares-are-trading-higher-wednesday-whats-going-on
Travere Shares Are Trading Higher Wednesda...
09/10/2025 19:52:26

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/10/2025 17:07:06

hc-wainwright--co-reiterates-buy-on-travere-therapeutics-maintains-47-price-target
HC Wainwright & Co. Reiterates Buy on Trav...
09/10/2025 16:40:59

HC Wainwright & Co. analyst Joseph Pantginis reiterates Travere Therapeutics (NASDAQ:TVTX) with a Buy and maintains $47 ...

daktronics-potbelly-coreweave-gamestop-and-other-big-stocks-moving-higher-on-wednesday
Daktronics, Potbelly, CoreWeave, GameStop ...
09/10/2025 14:56:32

travere-therapeutics-announces-fda-drops-advisory-committee-for-filspari-snda-in-fsgs-pdufa-target-date-set-for-january-13-2026
Travere Therapeutics Announces FDA Drops A...
09/10/2025 11:03:38

Travere Therapeutics, Inc., (NASDAQ:TVTX) today announced that the U.S. Food and Drug Administration (FDA) has informed the Com...

hc-wainwright--co-reiterates-buy-on-travere-therapeutics-maintains-47-price-target
HC Wainwright & Co. Reiterates Buy on Trav...
09/03/2025 14:41:49

HC Wainwright & Co. analyst Joseph Pantginis reiterates Travere Therapeutics (NASDAQ:TVTX) with a Buy and maintains $47 ...

update-travere-therapeutics-presents-long-term-safety-and-efficacy-data-for-pegtibatinase-in-classical-homocystinuria
UPDATE: Travere Therapeutics Presents Long...
09/03/2025 12:46:01

Presentation details long-term safety and efficacy data on pegtibatinase as a potential treatment for classical HCUTravere Ther...

fda-eases-monitoring-burden-for-kidney-disease-patients-on-travere-therapeutics-filspari
FDA Eases Monitoring Burden For Kidney Dis...
08/28/2025 16:40:43

FDA eases REMS labeling for Travere's Filspari, reducing liver monitoring and removing embryo-fetal toxicity rules, with FS...

nvidia-to-rally-around-27-here-are-10-top-analyst-forecasts-for-thursday
Nvidia To Rally Around 27%? Here Are 10 To...
08/28/2025 13:34:02

deep-dive-into-travere-therapeutics-stock-analyst-perspectives-6-ratings
Deep Dive Into Travere Therapeutics Stock:...
08/28/2025 12:00:30

hc-wainwright--co-maintains-buy-on-travere-therapeutics-raises-price-target-to-47
HC Wainwright & Co. Maintains Buy on Trave...
08/28/2025 10:45:38

HC Wainwright & Co. analyst Joseph Pantginis maintains Travere Therapeutics (NASDAQ:TVTX) with a Buy and raises the pric...

travere-therapeutics-announces-fda-eases-filspari-liver-monitoring-from-monthly-to-every-3-months-removes-embryo-fetal-toxicity-rems-requirement
Travere Therapeutics Announces FDA Eases F...
08/27/2025 21:10:29

FDA simplifies liver monitoring schedule from monthly to every three months for the duration of treatment and removes embryo-fe...

hedge-fund-viking-global-dumps-unitedhealth-loads-up-on-amd-disney-jpmorgan-in-q2-shake-up
Hedge Fund Viking Global Dumps UnitedHealt...
08/15/2025 12:17:07

Andreas Halvorsen's Viking Global adjusted its stock portfolio in Q2, cutting healthcare exposure and adding consumer brand...

wedbush-maintains-outperform-on-travere-therapeutics-raises-price-target-to-32
Wedbush Maintains Outperform on Travere Th...
08/07/2025 12:38:21

Wedbush analyst Laura Chico maintains Travere Therapeutics (NASDAQ:TVTX) with a Outperform and raises the price target from ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION